Stay updated on Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.

Latest updates to the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe study record shows recruitment status updated to Active, not recruiting as of 2026-05-18, and the revision tag was updated to v3.5.4. This reflects a maintenance update to the public record.SummaryDifference0.3%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedTaoyuan, Taiwan, 333 was added to the Locations section and Taoyuan District, Taiwan, 333 was removed, updating the list of participating sites in Taiwan.SummaryDifference0.0%

- Check22 days agoChange DetectedOn 2026-04-23, the record was updated to include the recruitment statuses 'Active, not recruiting' and 'Withdrawn', and the earlier 'Not yet recruiting' designation was removed. The update captures changes in enrollment activity and study viability across sites.SummaryDifference0.2%

- Check30 days agoChange DetectedUpdated the spelling of a location entry (diacritics removed) and the displayed site revision version.SummaryDifference0.0%

- Check59 days agoChange DetectedUpdated recruitment location from Gurgaon, India, 122001 to Gūrgaon, India, 122001 and bumped revision to v3.5.0.SummaryDifference0.0%

- Check66 days agoChange DetectedStandardized the India location spelling from Gūrgaon to Gurgaon (122001) for the recruitment site.SummaryDifference0.0%

Stay in the know with updates to Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durva + Domva After ChemoRad in Stage III NSCLC Clinical Trial page.